1
Clinical Trials associated with CMV specific adoptive t-cells(Case Comprehensive Cancer Center)Antigen Specific Adoptive T Cell Therapy for Opportunistic Cytomegalovirus Infection Occurring After Stem Cell Transplant
The purpose of this study is to determine if a specific type of cell-based immunotherapy, using T-cells from a donor that are specific against cytomegalovirus (CMV) is feasible to treat infections by CMV.
Adoptive T-cell therapy is an investigational (experimental) therapy that works by using the blood of a donor and selecting the T-cells that can respond against a specific infectious entity. These selected T-cells are then infused to the patient, to try to give the immune system the ability to fight the infection. Adoptive T-cell therapy is experimental because it is not approved by the Food and Drug Administration (FDA).
Start Date27 May 2020 |
Sponsor / Collaborator- |
100 Clinical Results associated with CMV specific adoptive t-cells(Case Comprehensive Cancer Center)
100 Translational Medicine associated with CMV specific adoptive t-cells(Case Comprehensive Cancer Center)
100 Patents (Medical) associated with CMV specific adoptive t-cells(Case Comprehensive Cancer Center)
100 Deals associated with CMV specific adoptive t-cells(Case Comprehensive Cancer Center)